SENIOR SECURED CONVERTIBLE DEBENTURE DUE ___________ [2017]Pressure Biosciences Inc • July 28th, 2015 • Laboratory analytical instruments • New York
Company FiledJuly 28th, 2015 Industry JurisdictionTHIS SENIOR SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Secured Convertible Debentures of Pressure BioSciences, Inc., a Massachusetts corporation, (the “Company”), having its principal place of business at 14 Norfolk Avenue, South Easton, Massachusetts 02375, designated as its Senior Secured Convertible Debenture due plus accrued Interest thereon not previously paid (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC.Pressure Biosciences Inc • July 28th, 2015 • Laboratory analytical instruments • New York
Company FiledJuly 28th, 2015 Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______ (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITY AGREEMENTSecurity Agreement • July 28th, 2015 • Pressure Biosciences Inc • Laboratory analytical instruments • New York
Contract Type FiledJuly 28th, 2015 Company Industry JurisdictionThis SECURITY AGREEMENT, dated as of July 21, 2015 (this “Agreement”), is among Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), and [PLACEMENT AGENT] as collateral agent (the “Agent”) for the holders of the Company’s Secured Convertible Debentures in the original aggregate principal amount of $1,672,000 (collectively, the “Debentures”), their endorsees, transferees and assigns as set forth on Schedule H, as amended from time to time (collectively, the “Secured Parties”).